No date for the meeting, just that the request to

No date for the meeting, just that the request to meet should be submitted Monday and as FDA will have all of the HIV mono-therapy data with the BLA update the request will ask for both the HIV-combo and HIV-mono to be included in the application review. If approved this would be a significant increase in the LLM HIV market, a much welcomed positive outcome.